Stem cells: An emerging novel therapeutic for type-1 diabetes mellitus.

Diabetes Res Clin Pract

Department of Regenerative Medicine and Stem Cell Therapy and Pediatrics, G.R. Doshi and K.M. Mehta Institute of Kidney Diseases & Research Centre (IKDRC), Dr. H.L. Trivedi Institute of Transplantation Sciences (ITS), India; Department of Nephrology and Transplantation Medicine, G.R. Doshi and K.M. Mehta Institute of Kidney Diseases & Research Centre (IKDRC), Dr. H.L. Trivedi Institute of Transplantation Sciences (ITS), India.

Published: August 2017

Stem cell based strategies are therapeutically potent for treating type-1 diabetes mellitus owing to their intrinsic regenerative capacity and immunomodulatory properties to arrest autoimmune β-cell destruction, preserve residual β-cell mass, facilitate endogenous regeneration, ameliorate innate/ alloimmune graft rejection, restore β-cell-specific unresponsiveness in absence of chronic immunosuppression and to reverse hyperglycemia.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.diabres.2017.04.014DOI Listing

Publication Analysis

Top Keywords

type-1 diabetes
8
diabetes mellitus
8
stem cells
4
cells emerging
4
emerging novel
4
novel therapeutic
4
therapeutic type-1
4
mellitus stem
4
stem cell
4
cell based
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!